CD8A and cancer: Mechanically, intratumoral inoculation of the ΔGRA17 mutant T. gondii strain can activate CD4+ T cells, CD8+ T cells and NK cells and decrease the expression of PD-1 in CD8+ T cells of hosts to improve immunological response to anti-cancer therapy.